Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04775277

Enrollment

Registered

2021-03-01

Start date

2018-12-01

Completion date

2021-02-20

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

IPF, pregnancy

Brief summary

case-control study was conducted between December 2018 to April 2020. To document outcome of IPF with pregnancy.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 38 Years

Inclusion criteria

* Patients with pulmonary diseases during pregnancy

Exclusion criteria

* Patients with pulmonary diseases other than IPF and bronchial asthma were excluded.

Design outcomes

Primary

Measure	Time frame	Description
any adverse events including gestational complication or disease specific complication	from the start of inclusion to the study till termination of pregnancy, average 9 months period	e.g (development of respiratory failure, need for ICU admission). maternal outcome
neonatal outcome	December 2018 to April 2020	any unfavorable neonatal outcome as low birth weight

Countries

Egypt

Outcome results